+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Contraceptives Market 2019-2027

  • ID: 4772830
  • Report
  • Region: Europe
  • 111 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 3

FEATURED COMPANIES

  • Afaxys, Inc.
  • Allergan Inc.
  • Church & Dwight Co., Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Okamoto Industries, Inc
  • MORE
Market Outlook

The Europe contraceptive market is projected to escalate at a CAGR of 6.58% during the forecast years 2019-2027. Germany, France, the UK, Spain, Italy, Russia and rest of Europe are countries analyzed in this market.

The government has introduced various educational programs on the importance of birth control owing to the rising population. Using contraceptives is an effective method to keep population growth in check. Unintended pregnancies which were traditionally avoided by abortions are now being evaded with the use of contraceptives. Contraceptives are extremely effective in evading the occurrence of STIs. Along with being safe and reliable, contraceptives also show a high success rate. Thus, owing to the various benefits of contraceptives, the contraceptive market has shown immense progress in the Europe market.

The European contraceptive market can be classified based on age groups, education, drugs & drivers and end users. Contraceptives are used by people falling in the age group 15-24, 25-34, 35-44 and 45 and above. Households, clinics and hospitals are places wherein contraceptives are generally used.

Despite the numerous advantages that contraceptives offer, individuals are hesitant to use contraceptives due to the risk of side-effects. Also, many misperceptions surrounding the use of contraceptives are hampering the market growth.

Competitive Outlook

The major contraceptive-manufacturing companies in the market are Cooper Surgical, Inc., Afaxys, Inc., Okamoto Industries, Inc., Teva Pharmaceutical Industries, Ltd., Mayer Laboratories, Inc., Ocon Medical, Ltd., SMB Corporation, Reckitt Benckiser PLC, Allergan, Inc., Melbea, Apothecus Pharmaceutical Corporation, Merck & Co., Inc., Pregna, Agile Therapeutics, Church & Dwight Co., Inc., Bayer AG and Pfizer, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Afaxys, Inc.
  • Allergan Inc.
  • Church & Dwight Co., Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Okamoto Industries, Inc
  • MORE
1. Contraceptive Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threat of New Entrants
2.2.2. Threat of Substitute
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Threat of Competitive Rivalry
2.3. Regulatory Outlook
2.4. Pestel Outlook
2.5. Market Attractiveness Index
2.6. Market Player Positioning
2.7. Key Insights
2.7.1. Oral Contraceptive Are the Majorly Used Contraceptive Drugs
2.7.2. Condoms Are the Widely Used Contraceptives Device
2.7.3. Age Group of 15–24 Years Are the Major Revenue Contributors to the Europe Contraceptive Market
2.8. Market Drivers
2.8.1. Growing Cognizance For Contraceptives
2.8.2. Increasing Usage of Oral Contraceptives to Evade Unplanned Pregnancy
2.8.3. Surge in the Initiatives of Government and Ngo
2.8.4. Growing Awareness About Std
2.9. Market Restraints
2.9.1. Side Effects Restricting the Growth of Contraceptives
2.9.2. Limited Access to Contraceptives
2.10. Market Opportunities
2.10.1. Rising Disposable Income in Emerging Economies
2.10.2. Unmet Medical Needs in the Emerging Economies
2.10.3. Technological Advancements
2.11. Market Challenges
2.11.1. Lack of Acceptance of Society

3. Contraceptive Market Outlook - By Education
3.1. Less Than High School
3.2. High School Graduate
3.3. College Graduate
3.4. Other College Degrees

4. Contraceptive Market Outlook - By Age Group
4.1. 15–24 Years
4.2. 25–34 Years
4.3. 35–44 Years
4.4. Above 44 Years

5. Contraceptive Market Outlook - By End User
5.1. Households
5.2. Clinics
5.3. Hospitals

6. Contraceptive Market Outlook - By Drugs and Devices
6.1. Contraceptives Drugs
6.1.1. Oral Contraceptive Pills
6.1.2. Injectable Contraceptives
6.1.3. Topical Contraceptives
6.2. Contraceptive Devices
6.2.1. Male Condoms
6.2.2. Female Condoms
6.2.3. Diaphragms
6.2.4. Contraceptive Sponges
6.2.5. Vaginal Rings
6.2.6. Subdermal Implants
6.2.7. Intra-Uterine Devices
6.2.7.1. Copper Intra-Uterine Devices
6.2.7.2. Hormonal Intra-Uterine Devices

7. Contraceptive Market - Regional Outlook
7.1. Europe
7.1.1. Country Analysis
7.1.1.1. Germany
7.1.1.2. France
7.1.1.3. The United Kingdom
7.1.1.4. Spain
7.1.1.5. Italy
7.1.1.6. Russia
7.1.1.7. Rest of Europe

8. Competitive Landscape
8.1. Company Profiles
8.1.1. Allergan Inc.
8.1.2. Bayer Ag
8.1.3. Melbea
8.1.4. Pregna
8.1.5. Pfizer, Inc.
8.1.6. Church & Dwight Co., Inc.
8.1.7. Afaxys, Inc.
8.1.8. Apothecus Pharmaceutical Corporation
8.1.9. Cooper Surgical Inc
8.1.10. Okamoto Industries, Inc
8.1.11. Mayer Laboratories, Inc.
8.1.12. Agile Therapeutics
8.1.13. Merck & Co., Inc.
8.1.14. Reckitt Benckiser Plc
8.1.15. Smb Corporation
8.1.16. Teva Pharmaceutical Industries Ltd.
8.1.17. Ocon Medical Ltd

9. Methodology & Scope
9.1. Research Scope
9.2. Sources of Data
9.3. Research Methodology

List of Tables
Table 1 Europe Contraceptive Market 2019-2027 ($ Million)
Table 2 Contraceptive Market Player Positioning Outlook 2017
Table 3 Europe Contraceptive Market By Education 2019-2027 ($ Million)
Table 4 Europe Contraceptive Market By Age Group 2019-2027 ($ Million)
Table 5 Europe Contraceptive Market By End User 2019-2027 ($ Million)
Table 6 Europe Contraceptive Market By Drugs and Devices 2019-2027 ($ Million)
Table 7 Europe Contraceptives Drugs Market By Type 2019-2027 ($ Million)
Table 8 Europe Contraceptive Devices Market By Type 2019-2027 ($ Million)
Table 9 Europe Intra-Uterine Devices Market By Type 2019-2027 ($ Million)
Table 10 Europe Contraceptive Market By Country 2019-2027 ($ Million)

List of Figures
Figure 1 Europe Contraceptive Market 2019-2027 ($ Million)
Figure 2 Porter's Five Force Model
Figure 3 Europe Contraceptive Market By Less Than High School 2019-2027 ($ Million)
Figure 4 Europe Contraceptive Market By High School Graduate 2019-2027 ($ Million)
Figure 5 Europe Contraceptive Market By College Graduate 2019-2027 ($ Million)
Figure 6 Europe Contraceptive Market By Other College Degrees 2019-2027 ($ Million)
Figure 7 Europe Contraceptive Market By 15–24 Years 2019-2027 ($ Million)
Figure 8 Europe Contraceptive Market By 25–34 Years 2019-2027 ($ Million)
Figure 9 Europe Contraceptive Market By 35–44 Years 2019-2027 ($ Million)
Figure 10 Europe Contraceptive Market By Above 44 Years 2019-2027 ($ Million)
Figure 11 Europe Contraceptive Market By Households 2019-2027 ($ Million)
Figure 12 Europe Contraceptive Market By Clinics 2019-2027 ($ Million)
Figure 13 Europe Contraceptive Market By Hospitals 2019-2027 ($ Million)
Figure 14 Europe Contraceptive Market By Contraceptives Drugs 2019-2027 ($ Million)
Figure 15 Europe Contraceptives Drugs Market By Oral Contraceptive Pills 2019-2027 ($ Million)
Figure 16 Europe Contraceptives Drugs Market By Injectable Contraceptives 2019-2027 ($ Million)
Figure 17 Europe Contraceptives Drugs Market By Topical Contraceptives 2019-2027 ($ Million)
Figure 18 Europe Contraceptive Market By Contraceptive Devices 2019-2027 ($ Million)
Figure 19 Europe Contraceptive Devices Market By Male Condoms 2019-2027 ($ Million)
Figure 20 Europe Contraceptive Devices Market By Female Condoms 2019-2027 ($ Million)
Figure 21 Europe Contraceptive Devices Market By Diaphragms 2019-2027 ($ Million)
Figure 22 Europe Contraceptive Devices Market By Contraceptive Sponges 2019-2027 ($ Million)
Figure 23 Europe Contraceptive Devices Market By Vaginal Rings 2019-2027 ($ Million)
Figure 24 Europe Contraceptive Devices Market By Subdermal Implants 2019-2027 ($ Million)
Figure 25 Europe Contraceptive Devices Market By Intra-Uterine Devices 2019-2027 ($ Million)
Figure 26 Europe Intra-Uterine Devices Market By Copper Intra-Uterine Devices 2019-2027 ($ Million)
Figure 27 Europe Intra-Uterine Devices Market By Hormonal Intra-Uterine Devices 2019-2027 ($ Million)
Figure 28 Germany Contraceptive Market 2019-2027 ($ Million)
Figure 29 France Contraceptive Market 2019-2027 ($ Million)
Figure 30 the United Kingdom Contraceptive Market 2019-2027 ($ Million)
Figure 31 Spain Contraceptive Market 2019-2027 ($ Million)
Figure 32 Italy Contraceptive Market 2019-2027 ($ Million)
Figure 33 Russia Contraceptive Market 2019-2027 ($ Million)
Figure 34 Rest of Europe Contraceptive Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Inc.
  • Bayer AG
  • Melbea
  • Pregna
  • Pfizer, Inc.
  • Church & Dwight Co., Inc.
  • Afaxys, Inc.
  • Apothecus Pharmaceutical Corporation
  • Cooper Surgical Inc
  • Okamoto Industries, Inc
  • Mayer Laboratories, Inc.
  • AGile Therapeutics
  • Merck & Co., Inc.
  • Reckitt Benckiser plc
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Ocon Medical
Note: Product cover images may vary from those shown
Adroll
adroll